Success Metrics

Clinical Success Rate
100.0%

Based on 5 completed trials

Completion Rate
100%(5/5)
Active Trials
0(0%)
Results Posted
40%(2 trials)

Phase Distribution

Ph phase_4
3
50%
Ph phase_1
2
33%
Ph phase_3
1
17%

Phase Distribution

2

Early Stage

0

Mid Stage

4

Late Stage

Phase Distribution6 total trials
Phase 1Safety & dosage
2(33.3%)
Phase 3Large-scale testing
1(16.7%)
Phase 4Post-market surveillance
3(50.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

5 of 5 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

6

all time

Status Distribution
Completed(5)
Other(1)

Detailed Status

Completed5
unknown1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 12 (33.3%)
Phase 31 (16.7%)
Phase 43 (50.0%)

Trials by Status

completed583%
unknown117%

Recent Activity

0 active trials
Showing 5 of 6
unknownphase_1

Bioequivalence Study of Amlodipine/Valsartan 10/160 mg Film Coated Tablets

NCT06193044
completedphase_3

Efficacy and Safety of Valsartan and Amlodipine (± HCTZ) in Adults With Moderate, Inadequately Controlled Hypertension

NCT00523744
completedphase_4

Study of Efficacy and Safety of CVAA489 in Hypertensive Patients

NCT02062645
completedphase_4

PMS Study of Amlodipine/Valsartan for the Treatment of Hypertension

NCT02058446
completedphase_1

A Bioequivalence Study of Amlodipine / Valsartan From Amlodipine/Valsartan 10/160 Tablets (Pharmacare, Palestine) and Exforge Tablets (Novartis Pharma, USA)

NCT02519010
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT06193044Phase 1

Bioequivalence Study of Amlodipine/Valsartan 10/160 mg Film Coated Tablets

Unknown
NCT00523744Phase 3

Efficacy and Safety of Valsartan and Amlodipine (± HCTZ) in Adults With Moderate, Inadequately Controlled Hypertension

Completed
NCT02062645Phase 4

Study of Efficacy and Safety of CVAA489 in Hypertensive Patients

Completed
NCT02058446Phase 4

PMS Study of Amlodipine/Valsartan for the Treatment of Hypertension

Completed
NCT02519010Phase 1

A Bioequivalence Study of Amlodipine / Valsartan From Amlodipine/Valsartan 10/160 Tablets (Pharmacare, Palestine) and Exforge Tablets (Novartis Pharma, USA)

Completed
NCT01819220Phase 4

Randomized, Open Labeled Clinical Trial to Compare the Effectiveness of Amlodipine/Valsartan vs Hydrochlorothiazide/Telmisartan on Glucose Tolerance in Patients With Hypertension With Metabolic Syndrome

Completed

All 6 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
6